research use only
Cat.No.S6387
| Related Targets | Akt Wnt/beta-catenin PKC HSP ROCK Microtubule Associated Bcr-Abl Actin FAK Kinesin |
|---|---|
| Other Integrin Inhibitors | SB273005 Cilengitide trifluoroacetate RGD peptide (Arg-Gly-Asp) ATN-161 Cyclo(RGDyK) TFA Cyclo(-RGDfK) TFA Leukadherin-1 A-205804 RGD peptide (GRGDNP) Pyrintegrin |
|
In vitro |
DMSO
: 100 mg/mL
(169.87 mM)
Water : 5 mg/mL (超声加热十分钟,60℃) Ethanol : Insoluble The solubility data above are all experimental results (not literature values). |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
Read more about Cilengitide (EMD 121974) solubility in DMSO or water
Read more about Cilengitide (EMD 121974) working concentrations for cell culture treatment
Cilengitide (EMD 121974) is a potent inhibitor of αvβ3 (5400 ± 814 nM) and αvβ5. Cilengitide (EMD 121974) exhibits the greatest inhibitory potency toward αvβ3 (IC50 = 5400 ± 814 nM).
| Information | Cilengitide is a potent, selective cyclic RGD peptide and integrin αvβ3/αvβ5 antagonist. It affects FAK/Src/AKT, TGF-β1/Smad, and Ras/ERK/AKT signaling pathways by blocking integrin-mediated signaling, effectively inhibiting tumor cell adhesion, migration, and proliferation, and promoting apoptosis. |
|---|---|
|
Read more about Cilengitide (EMD 121974) IC50 for cell-based and cell-free assays |
|
| Primary Applications and Mechanism of Action | |
Read more about Cilengitide (EMD 121974) Mechanism of Action
| Molecular Weight | 588.66 | Formula | C27H40N8O7 |
Storage (From the date of receipt) | 3 years -20°C powder |
|---|---|---|---|---|---|
| CAS No. | 188968-51-6 | -- | Storage of Stock Solutions |
|
|
| Synonyms | EMD 121974, EMD-12192, EMD-85189, NSC-707544 | Smiles | CC(C)C1N(C)C(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(O)=O)NC(=O)CNC(=O)C(CCCNC(N)=N)NC1=O | ||
Read more comparative analysis about Cilengitide (EMD 121974)
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.